Eckert & Ziegler Strahlen- und Medizintechnik AG, through its subsidiaries, manufactures and sells isotope technology components for medical, scientific, and industrial applications worldwide. It operates in two segments, Medical and Isotope Products. The Medical segment offers small radioactive implants for the treatment of prostate cancer seeds; and eye application based on ruthenium-106 or iodine-125 for treating uveal melanoma. This segment also provides radiopharmaceuticals, laboratory equipment, hot cells, and services for radiopharmaceuticals, as well as eye applicators and prostate implants. The Isotope Products segment manufactures and sells radiation sources for imaging, measurement technology, material analysis, quality assurance, and environmental monitoring. This segment also offers calibration sources for medical imaging systems, and homeland security and radiometric level measurement products. The company was founded in 1992 and is headquartered in Berlin, Germany.
Eckert & Ziegler Strahlen- und Medizintechnik Dividend Announcement
• Eckert & Ziegler Strahlen- und Medizintechnik announced a semi annually dividend of €0.05 per ordinary share which will be made payable on 2024-07-01. Ex dividend date: 2024-06-27
• Eckert & Ziegler Strahlen- und Medizintechnik annual dividend for 2024 was €0.55
• Eckert & Ziegler Strahlen- und Medizintechnik annual dividend for 2023 was €0.50
• Eckert & Ziegler Strahlen- und Medizintechnik's trailing twelve-month (TTM) dividend yield is 1.38%
• Eckert & Ziegler Strahlen- und Medizintechnik's dividend growth over the last five years (2018-2023) was -8.97% year
• Eckert & Ziegler Strahlen- und Medizintechnik's dividend growth over the last ten years (2013-2023) was -1.81% year
Eckert & Ziegler Strahlen- und Medizintechnik Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-06-27 | €0.05 | semi annually | 2024-07-01 |
2024-05-29 | €0.50 | semi annually | |
2023-06-08 | €0.50 | semi annually | 2023-06-12 |
2022-06-02 | €0.50 | semi annually | 2022-06-06 |
2021-06-03 | €0.45 | semi annually | 2021-06-07 |
2020-06-18 | €6.80 | semi annually | |
2020-06-11 | €1.70 | semi annually | 2020-06-15 |
2019-05-30 | €1.20 | semi annually | 2019-06-03 |
2018-05-31 | €0.80 | semi annually | 2018-06-04 |
2017-06-01 | €0.06 | semi annually | 2017-06-06 |
2016-06-09 | €0.60 | semi annually | 2016-06-09 |
2015-06-04 | €0.60 | semi annually | 2015-06-04 |
2014-05-23 | €0.60 | semi annually | 2014-05-23 |
2013-05-20 | €0.60 | semi annually | 2013-05-20 |
Eckert & Ziegler Strahlen- und Medizintechnik Dividend per year
Eckert & Ziegler Strahlen- und Medizintechnik Dividend growth
Eckert & Ziegler Strahlen- und Medizintechnik Dividend Yield
Eckert & Ziegler Strahlen- und Medizintechnik current trailing twelve-month (TTM) dividend yield is 1.38%. Interested in purchasing Eckert & Ziegler Strahlen- und Medizintechnik stock? Use our calculator to estimate your expected dividend yield:
Eckert & Ziegler Strahlen- und Medizintechnik Financial Ratios
Eckert & Ziegler Strahlen- und Medizintechnik Dividend FAQ
Other factors to consider when evaluating Eckert & Ziegler Strahlen- und Medizintechnik as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Eckert & Ziegler Strahlen- und Medizintechnik stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Eckert & Ziegler Strahlen- und Medizintechnik's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Eckert & Ziegler Strahlen- und Medizintechnik publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Eckert & Ziegler Strahlen- und Medizintechnik distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Eckert & Ziegler Strahlen- und Medizintechnik are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Eckert & Ziegler Strahlen- und Medizintechnik sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Eckert & Ziegler Strahlen- und Medizintechnik distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Eckert & Ziegler Strahlen- und Medizintechnik declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Eckert & Ziegler Strahlen- und Medizintechnik's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Eckert & Ziegler Strahlen- und Medizintechnik's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.